Evaluation of Treatment Strategies for Patients with Stage IIIA Non-Small Cell Lung Cancer in the Immunotherapy Era

被引：0
|
作者：
Alabaster, A. [1 ]
Velotta, J. B. [2 ]
Tupper, H. I. [3 ]
Natanzon, Y. [1 ]
机构：
[1] ConcertAI, Cambridge, MA USA
[2] Kaiser Permanente, Oakland, CA USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Stage IIIA; Surgery; Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-34
引用
收藏
页码：S584 / S585
页数：2
相关论文
共 50 条
  • [31] Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer
    Ahn, YC
    Park, K
    Kim, DY
    Kim, KM
    Kim, J
    Shim, YM
    Lee, KS
    Han, JH
    Kim, HJ
    Kwon, OJ
    Lim, DH
    Noh, YJ
    Lee, JE
    Huh, SJ
    ACTA ONCOLOGICA, 2001, 40 (05) : 588 - 592
  • [32] Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients
    Timotheadou, Eleni
    Skarlos, Dimostfienis-Vasilios
    Samantas, Epaminondas
    Papadopoulos, Savvas
    Murray, Sam
    Skrickova, Jana
    Christodoulou, Christos
    Papakostantinou, Christos
    Pectasides, Dimitrios
    Papakostas, Pavlos
    Kaplanova, Jana
    Vrettou, Eleni
    Karina, Maria
    Kosmidis, Paraskevas
    Fountzilas, George
    ANTICANCER RESEARCH, 2007, 27 (6C) : 4481 - 4489
  • [33] Clinical evaluation of postoperative chemotherapy based on genetic testing in patients with stage IIIA non-small cell lung cancer
    Miao, Jinbai
    Zhang, Wenqian
    Hu, Xiaoxing
    Chen, Shuo
    Hu, Bin
    Li, Hui
    THORACIC CANCER, 2016, 7 (01) : 44 - 49
  • [34] Advances in the Treatment of Non-Small Cell Lung Cancer: Immunotherapy
    Patel, Shetal A.
    Weiss, Jared
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 237 - +
  • [35] Treatment strategy for patients with surgically discovered N2 stage IIIA non-small cell lung cancer
    Nakanishi, R
    Osaki, T
    Nakanishi, K
    Yoshino, I
    Yoshimatsu, T
    Watanabe, H
    Nakata, H
    Yasumoto, K
    ANNALS OF THORACIC SURGERY, 1997, 64 (02): : 342 - 348
  • [36] Stage and treatment migration in patients with stage III non-small cell lung cancer
    Hubbs, J. L.
    Fatunase, T.
    Hollis, D. R.
    Clough, R. W.
    Kelsey, C. R.
    D'Amico, T. A.
    Marks, L. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S159 - S160
  • [37] Dendritic Cell Based Immunotherapy in Stage IIB-IIIA Non-Small Cell Lung Cancer Patients: 10-Years Experience
    Khranovska, N.
    Skachkova, O.
    Gorbach, O.
    Sovenko, V.
    Ganul, A.
    Inomistova, M.
    Orel, V.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S739 - S739
  • [38] Neoadjuvant Immunotherapy for Patients With Non-Small Cell Lung Cancer-Is a New Era Coming?
    Zhang, Bo
    Zhong, Hua
    Han, Baohui
    JAMA ONCOLOGY, 2023, 9 (03) : 301 - 302
  • [39] Neoadjuvant Immunotherapy for Patients with non-small cell Lung Cancer
    Luecke, E.
    Ganzert, C.
    Waesche, A.
    Walles, T.
    Schreiber, J.
    PNEUMOLOGIE, 2020, 74 : S74 - S75
  • [40] Multidisciplinary treatment for stage IIIA non-small cell lung cancer (NSCLC): Does institution matter?
    Samson, Pamela Parker
    Patel, Aalok
    Crabtree, Traves
    Morgensztern, Daniel
    Robinson, Cliff Grant
    Colditz, Graham A.
    Waqar, Saiama Naheed
    Kreisel, Daniel
    Patterson, G. Alexander
    Krupnick, Alexander Sasha
    Broderick, Stephen R.
    Meyers, Bryan F.
    Purl, Varun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345